vs
Grindr Inc.（GRND）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Grindr Inc.的1.6倍（$207.3M vs $126.0M），Grindr Inc.净利率更高（16.1% vs -62.0%，领先78.1%），Grindr Inc.同比增速更快（29.0% vs 25.9%），Grindr Inc.自由现金流更多（$24.5M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 29.3%）
Grindr是面向LGBTQ群体的定位类社交应用，基于地理位置匹配功能帮助同群体用户便捷建立联系、拓展社交圈，是全球范围内该群体中认知度较高的社交服务平台之一。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GRND vs RARE — 直观对比
营收规模更大
RARE
是对方的1.6倍
$126.0M
营收增速更快
GRND
高出3.2%
25.9%
净利率更高
GRND
高出78.1%
-62.0%
自由现金流更多
GRND
多$125.3M
$-100.8M
两年增速更快
RARE
近两年复合增速
29.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $126.0M | $207.3M |
| 净利润 | $20.3M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 24.9% | -54.7% |
| 净利率 | 16.1% | -62.0% |
| 营收同比 | 29.0% | 25.9% |
| 净利润同比 | 116.4% | 3.5% |
| 每股收益（稀释后） | $0.10 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GRNDRARE
| Q4 25 | $126.0M | $207.3M | ||
| Q3 25 | $115.8M | $159.9M | ||
| Q2 25 | $104.2M | $166.5M | ||
| Q1 25 | $93.9M | $139.3M | ||
| Q4 24 | $97.6M | $164.6M | ||
| Q3 24 | $89.3M | $139.5M | ||
| Q2 24 | $82.3M | $147.0M | ||
| Q1 24 | $75.3M | $108.8M |
净利润GRNDRARE
| Q4 25 | $20.3M | $-128.6M | ||
| Q3 25 | $30.8M | $-180.4M | ||
| Q2 25 | $16.6M | $-115.0M | ||
| Q1 25 | $27.0M | $-151.1M | ||
| Q4 24 | $-123.9M | $-133.2M | ||
| Q3 24 | $24.7M | $-133.5M | ||
| Q2 24 | $-22.4M | $-131.6M | ||
| Q1 24 | $-9.4M | $-170.7M |
营业利润率GRNDRARE
| Q4 25 | 24.9% | -54.7% | ||
| Q3 25 | 39.1% | -106.9% | ||
| Q2 25 | 23.4% | -64.8% | ||
| Q1 25 | 27.0% | -102.6% | ||
| Q4 24 | 20.9% | -74.3% | ||
| Q3 24 | 31.8% | -94.6% | ||
| Q2 24 | 29.8% | -79.1% | ||
| Q1 24 | 25.6% | -151.9% |
净利率GRNDRARE
| Q4 25 | 16.1% | -62.0% | ||
| Q3 25 | 26.6% | -112.8% | ||
| Q2 25 | 16.0% | -69.0% | ||
| Q1 25 | 28.8% | -108.5% | ||
| Q4 24 | -126.9% | -80.9% | ||
| Q3 24 | 27.6% | -95.7% | ||
| Q2 24 | -27.2% | -89.5% | ||
| Q1 24 | -12.5% | -156.8% |
每股收益（稀释后）GRNDRARE
| Q4 25 | $0.10 | $-1.28 | ||
| Q3 25 | $0.16 | $-1.81 | ||
| Q2 25 | $0.08 | $-1.17 | ||
| Q1 25 | $0.09 | $-1.57 | ||
| Q4 24 | $-0.65 | $-1.34 | ||
| Q3 24 | $0.09 | $-1.40 | ||
| Q2 24 | $-0.13 | $-1.52 | ||
| Q1 24 | $-0.05 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $87.0M | $421.0M |
| 总债务越低越好 | $395.9M | — |
| 股东权益账面价值 | $47.0M | $-80.0M |
| 总资产 | $531.0M | $1.5B |
| 负债/权益比越低杠杆越低 | 8.42× | — |
8季度趋势，按日历期对齐
现金及短期投资GRNDRARE
| Q4 25 | $87.0M | $421.0M | ||
| Q3 25 | $6.3M | $202.5M | ||
| Q2 25 | $120.8M | $176.3M | ||
| Q1 25 | $255.9M | $127.1M | ||
| Q4 24 | $59.2M | $174.0M | ||
| Q3 24 | $39.1M | $150.6M | ||
| Q2 24 | $16.3M | $480.7M | ||
| Q1 24 | $21.5M | $112.3M |
总债务GRNDRARE
| Q4 25 | $395.9M | — | ||
| Q3 25 | $279.9M | — | ||
| Q2 25 | $283.5M | — | ||
| Q1 25 | $287.0M | — | ||
| Q4 24 | $290.6M | — | ||
| Q3 24 | $294.1M | — | ||
| Q2 24 | $297.7M | — | ||
| Q1 24 | $315.0M | — |
股东权益GRNDRARE
| Q4 25 | $47.0M | $-80.0M | ||
| Q3 25 | $71.0M | $9.2M | ||
| Q2 25 | $187.7M | $151.3M | ||
| Q1 25 | $319.8M | $144.2M | ||
| Q4 24 | $-131.6M | $255.0M | ||
| Q3 24 | $-13.4M | $346.8M | ||
| Q2 24 | $-41.7M | $432.4M | ||
| Q1 24 | $-22.0M | $140.3M |
总资产GRNDRARE
| Q4 25 | $531.0M | $1.5B | ||
| Q3 25 | $439.2M | $1.2B | ||
| Q2 25 | $547.6M | $1.3B | ||
| Q1 25 | $679.4M | $1.3B | ||
| Q4 24 | $479.1M | $1.5B | ||
| Q3 24 | $456.3M | $1.5B | ||
| Q2 24 | $435.0M | $1.6B | ||
| Q1 24 | $437.7M | $1.3B |
负债/权益比GRNDRARE
| Q4 25 | 8.42× | — | ||
| Q3 25 | 3.94× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $24.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $24.5M | $-100.8M |
| 自由现金流率自由现金流/营收 | 19.5% | -48.6% |
| 资本支出强度资本支出/营收 | 0.2% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.22× | — |
| 过去12个月自由现金流最近4个季度 | $140.8M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流GRNDRARE
| Q4 25 | $24.8M | $-99.8M | ||
| Q3 25 | $55.4M | $-91.4M | ||
| Q2 25 | $37.5M | $-108.3M | ||
| Q1 25 | $23.8M | $-166.5M | ||
| Q4 24 | $29.5M | $-79.3M | ||
| Q3 24 | $29.1M | $-67.0M | ||
| Q2 24 | $15.8M | $-77.0M | ||
| Q1 24 | $20.4M | $-190.7M |
自由现金流GRNDRARE
| Q4 25 | $24.5M | $-100.8M | ||
| Q3 25 | $55.2M | $-92.7M | ||
| Q2 25 | $37.3M | $-110.7M | ||
| Q1 25 | $23.7M | $-167.8M | ||
| Q4 24 | $29.3M | $-79.5M | ||
| Q3 24 | $28.8M | $-68.6M | ||
| Q2 24 | $15.7M | $-79.0M | ||
| Q1 24 | $20.3M | $-193.9M |
自由现金流率GRNDRARE
| Q4 25 | 19.5% | -48.6% | ||
| Q3 25 | 47.7% | -58.0% | ||
| Q2 25 | 35.8% | -66.5% | ||
| Q1 25 | 25.2% | -120.5% | ||
| Q4 24 | 30.0% | -48.3% | ||
| Q3 24 | 32.2% | -49.2% | ||
| Q2 24 | 19.0% | -53.7% | ||
| Q1 24 | 26.9% | -178.2% |
资本支出强度GRNDRARE
| Q4 25 | 0.2% | 0.5% | ||
| Q3 25 | 0.2% | 0.8% | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.1% | 1.0% | ||
| Q4 24 | 0.3% | 0.1% | ||
| Q3 24 | 0.4% | 1.2% | ||
| Q2 24 | 0.2% | 1.4% | ||
| Q1 24 | 0.3% | 3.0% |
现金转化率GRNDRARE
| Q4 25 | 1.22× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | 2.25× | — | ||
| Q1 25 | 0.88× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GRND
| License And Service | $102.9M | 82% |
| Advertising | $23.1M | 18% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
